Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies
Degenerative Neurological and Neuromuscular Disease · 2017
DOI: 10.2147/dnnd.s100096 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Degenerative Neurological and Neuromuscular Disease, 2017. Verfasst von Jenny J Feng und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: NCATS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurology.
- Mellen Center for Multiple Sclerosis, Cleveland Clinic, Cleveland, OH, USA, ontaned@ccf.org.
Förderung
- NCATS NIH HHS
Zitieren
APA
Feng, J. J., & Ontaneda, D. (2017). Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies. Degenerative Neurological and Neuromuscular Disease. https://doi.org/10.2147/dnnd.s100096
Vancouver
Feng JJ, Ontaneda D. Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies. Degenerative Neurological and Neuromuscular Disease. 2017. doi:10.2147/dnnd.s100096
BibTeX
@article{Feng2017,
author = {Feng, Jenny J and Ontaneda, Daniel},
title = {Treating primary-progressive multiple sclerosis: potential of ocrelizumab and review of B-cell therapies},
journal = {Degenerative Neurological and Neuromuscular Disease},
year = {2017},
doi = {10.2147/dnnd.s100096}
}
EUVIMED